Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of the Combination Mepivacaine-Tramadol on the Success of Inferior Alveolar Nerve Block in Patients With Symptomatic Irreversible Pulpitis: a Randomized Clinical Trial.

NCT02110966 is registered in ClinicalTrials.gov with Daniel Chavarría Bolaños as lead sponsor.

NCT NCT02110966
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02110966 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of the Combination Mepivacaine-Tramadol on the Success of Inferior Alveolar Nerve Block in Patients With Symptomatic Irreversible Pulpitis: a Randomized Clinical Trial.
Lead sponsor
Daniel Chavarría Bolaños
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2014
Completion date
October 31, 2014
Enrollment
56 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

symptomatic irreversible pulpitis